Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease

Rolland C. Dickson, Norah A. Terrault, Michael Ishitani, K. Rajender Reddy, Patricia Sheiner, Velimir Luketic, Consuelo Soldevila-Pico, Michael Fried, Donald Jensen, Robert S. Brown, Gary Horwith, Richard Brundage, Anna Lok

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Keyphrases